These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26747023)

  • 1. Botulinum toxin type A as treatment of partially accommodative esotropia.
    Flores-Reyes EM; Castillo-López MG; Toledo-Silva R; Vargas-Ortega J; Murillo-Correa CE; Aguilar-Ruiz A
    Arch Soc Esp Oftalmol; 2016 Mar; 91(3):120-4. PubMed ID: 26747023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of the comitant adquired esotropia residual deviation].
    Fernández-Buenaga R; Won-Kim HR; Márquez-González C; Ruiz-Guerrero MF; Rodríguez-Sánchez JM
    Arch Soc Esp Oftalmol; 2011 Jul; 86(7):209-12. PubMed ID: 21798406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of botulinum toxin injection in patients with cerebral palsy and esotropia.
    Ameri A; Mirmohammadsadeghi A; Makateb A; Bazvand F; Hosseini S
    Strabismus; 2015; 23(1):8-13. PubMed ID: 25789846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery and botulinum toxin in congenital esotropia.
    Ruiz MF; Alvarez MT; Sánchez-Garrido CM; Hernáez JM; Rodríguez JM
    Can J Ophthalmol; 2004 Oct; 39(6):639-49. PubMed ID: 15559650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long term outcomes of botulinum toxin injections in infantile esotropia].
    Koudsie S; Coste-Verdier V; Paya C; Chan H; Andrebe C; Pechmeja J; Leoni S; Korobelnik JF
    J Fr Ophtalmol; 2021 Apr; 44(4):509-518. PubMed ID: 33632627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin in the treatment of partially accommodative esotropia with high AC/A ratio.
    Tejedor J; Gutiérrez-Carmona FJ
    PLoS One; 2020; 15(2):e0229267. PubMed ID: 32109950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of nonresolving consecutive exotropia following botulinum toxin treatment of childhood esotropia.
    Tejedor J; Rodríguez JM
    Arch Ophthalmol; 2007 Sep; 125(9):1210-3. PubMed ID: 17846360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Affecting the Efficacy of Botulinum Toxin Injection in the Treatment of Infantile and Partially Accommodative Esotropia.
    Alarfaj MA; Alsarhani WK; Alrashed SH; Alarfaj FA; Ahmad K; Awad A; Sesma G
    Middle East Afr J Ophthalmol; 2022; 29(3):122-126. PubMed ID: 37408716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of botulinum toxin with surgery as primary treatment for infantile esotropia.
    de Alba Campomanes AG; Binenbaum G; Campomanes Eguiarte G
    J AAPOS; 2010 Apr; 14(2):111-6. PubMed ID: 20451851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin injection as primary treatment for esotropia in patients with cerebral palsy.
    Malgorzata M; Wojciech K; Alina BŁ; Artur B
    Klin Oczna; 2013; 115(1):13-4. PubMed ID: 23882732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin uses in strabismus: A review of the injections performed during one year in a general hospital.
    Jarrín E; Arranz Márquez E; Yebra González L; García Gil de Bernabé J
    Arch Soc Esp Oftalmol; 2016 Mar; 91(3):114-9. PubMed ID: 26749329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin treatment in patients up to 3 years of age who have esotropic Duane retraction syndrome.
    Maya JF; de Liaño RG; Catalán MR; Rayward O
    Strabismus; 2013 Mar; 21(1):4-7. PubMed ID: 23477770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Success rates of botulinum toxin in different types of strabismus and dose effect.
    Niyaz L; Yeter V; Beldagli C
    Can J Ophthalmol; 2023 Jun; 58(3):239-244. PubMed ID: 35038409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of pediatric accommodative esotropia with botulinum toxin A treatment in Thailand.
    Wangtiraumnuay N; Surukrattanaskul S; Surakiatchanukul T; Masaya-Anon P; Hiriotappa J
    Strabismus; 2021 Mar; 29(1):26-33. PubMed ID: 33404269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Botulinum Toxin Type A in Cyclic Esotropia: A Long-Term Follow-up.
    Akyuz Unsal AI; Özkan SB; Ziylan S
    J Pediatr Ophthalmol Strabismus; 2019 Nov; 56(6):360-364. PubMed ID: 31743403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome and predictor variables in the treatment of acquired esotropia with botulinum toxin.
    Tejedor J; Rodríguez JM
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2542-6. PubMed ID: 11581195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results with botulinum toxin in patients with esotropia and psychomotor deficit].
    Arroyo-Yllanes ME; Pérez-Pérez JF; Murillo-Murillo L
    Cir Cir; 2009; 77(1):9-12. PubMed ID: 19228464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of bilateral botulinum toxin injections versus bilateral recessions of the medial rectus muscles for treatment of infantile esotropia.
    Gursoy H; Basmak H; Sahin A; Yildirim N; Aydin Y; Colak E
    J AAPOS; 2012 Jun; 16(3):269-73. PubMed ID: 22681945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical age of botulinum toxin treatment in essential infantile esotropia.
    Campos EC; Schiavi C; Bellusci C
    J Pediatr Ophthalmol Strabismus; 2000; 37(6):328-32; quiz 354-5. PubMed ID: 11392405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin treatment for esotropia.
    Donahue SP
    Am Orthopt J; 2013; 63():29-31. PubMed ID: 24260805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.